RSV Diagnostics Market: Global Industry Analysis and Forecast (2022-2029)

RSV Diagnostics Market is expected to reach US$ 1.94 Bn. at a CAGR of 9.12% during the forecast period 2029. RSV infection can be diagnosed using a range of laboratory techniques. While the American Academy of Pediatrics (AAP) does not typically suggest lab testing to diagnose RSV bronchiolitis (for which therapy is primarily supportive), confirmation of RSV infection may be necessary for high-risk populations if the results can guide therapeutic decisions. Antigen testing, molecular testing, and viral culture are all common methods of identification. RSV infection is generally treated with supportive care. Additional supportive therapies in infants hospitalized with RSV bronchiolitis include: • In babies with viral bronchiolitis, nebulized hypertonic saline has been proven to minimize hospitalization time and clinical severity. To reduce airway blockage, one suggested strategy is to reduce airway edema and mucus plugging. • Heliox, a combination of oxygen and helium, may alleviate respiratory discomfort within the first hour of therapy. It works by lowering airway resistance and the labor of breathing. It has not, however, been found to affect overall disease outcomes. • Chest physiotherapy has not been shown to lessen illness severity and is not prescribed consistently. Ribavirin is presently the only antiviral medicine approved for the treatment of RSV in children. It is a guanosine analog that inhibits viral RNA synthesis and capping. Presatovir, an investigational antiviral medication, showed excellent results in clinical studies but has yet to be authorized for medical use. By blocking the RSV F protein, it functions as a fusion inhibitor. RSV-specific and non-specific immunoglobins have traditionally been used to treat RSV-related sickness. However, there is presently inadequate data to justify the use of immunoglobins in RSV-infected children. Some of the leading key players in the global RSV Diagnostics Market include Abbott Laboratories, Dickinson and Company, and Thermo Fisher Scientific Inc. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares. RSV Diagnostics MarketTo know about the Research Methodology :- Request Free Sample Report

RSV Diagnostics Market Overview

Prevalence of technology and high rate of respiratory illness changed RSV diagnostics market. Respiratory Syncytial Virus (RSV), a virus that causes infection to the lower respiratory tract. This virus is a significant cause of chronic respiratory illness in babies who are prematurely born & are weak in immunity, and in children belonging to the age group of 0 to 5. Symptoms of this virus include a mild cold-illness to bronchiolitis and pneumonia. According to the data of the World Health Organization (WHO), pneumonia accounted for more than 15 % of children's deaths who are below five years of age. Often people around the world suffering from RSV infection recover without visiting any healthcare professional and undergoing any specific treatment or a practitioner to get tested. Besides this, symptoms can be much more serious and chronic in the geriatric population, young children, and in people with low immune systems which includes kids as well. And is a common cause of bacterial pneumonia in infants. Treatment for RSV is supportive that includes the use of humidified 02 and intravenous fluids for treating infants.

RSV Diagnostics Market Dynamics

The prevalence of high RSV infections among the geriatric population and infants combined with the increased rate of approval of diagnostic kits and assays by medical authorities impacted positively on the growth of the market. The growth of the market is also attributed to the presence of key market players such as bio- Rad laboratories, Abbott, and many others and their continuous focus on the development and introduction of new drugs and kits for the treatment of RSV. Doctors recommend testing of RSV when lungs sound abnormal upon hearing through a stethoscope. Test based on PCR molecular diagnostics poses the ability to screen multiple respiratory pathogens at once. Continuous development in the treatment method of RSV further boosted the market growth. Moreover, an increase in the adoption of molecular diagnostics and technological advancement in various diagnostic methods pushed the growth curve of the market upwards. Innovation in the detection of plasmonic techniques such as localized surface Plasmon resonance spectroscopy that uses metal-like Nano-materials by exploiting physiochemical properties offer more superiority and affordability compared to other techniques such as surface-enhanced Raman spectroscopy. Furthermore, other modernized techniques such as filament-based antibody detection in which testing can be done by using a one-step kit has further grown the market. However, certain factors such as the low detection limit of immunoassays combined with the growing rate of availability of RSV vaccines and drugs are restraining the market growth.

RSV Diagnostics Market Segment Analysis

By Method, the segment of molecular diagnostics dominated the RSV diagnostics market because of its high accuracy of detecting droplets. The various assays are being introduced for molecular diagnostic like, Flu/RSV XCassay, simplex Flu A/B, and Cepheid Xpert which impacted positively on the market growth. Molecular diagnostics detect the presence of genetic proteins or materials associated with the infection or health condition and facilitating practitioners for practicing personal medicine. Whereas, the segment of the Rapid Antigen Detection test is anticipated to be the fast-growing segment among others due to its advantages such as quick results, eliminating ancillary tastings, early diagnostic of the virus, and subsequently early treatment which has enhanced further market growth. Based on the end-user, the market is categorized into hospitals & clinics and laboratories & homecare. The segment of hospitals and clinics dominated the market because of an increased number of patients preferring visits to the hospital and clinic for the detection of RSV virus and infections. Moreover, increased adoption of point of care (POC) molecular diagnostic devices in hospitals & clinics in developing nations, growing demand for RSV detection among infants and the geriatric population has driven the segment's market growth. Whilst, the homecare segment is expected to grow fastest rate during the forecast period due to cost-effective treatment compared to the hospital stay and availability of adequately trained home healthcare professionals. By product type, Kit and assays dominated the market it is because of a growing number of patient base suffering from RSV infection and increasing demand for kits and assays by RSV diagnostic centers. These assay kits are used for scientific research, the discovery of drugs and development, and for a broad range of applications.

RSV Diagnostics Market Regional Insights:

North America dominated the RSV diagnostics market due to the rising number of patients suffering from this infection combined with the increased population during the forecast period. Molecular diagnostic and chromatography immunoassays are the most popular method used within the region because of their accuracy in providing results lead to towards its increased demand. Moreover, technological advancement in the diagnostic field, the presence of key market players of the pharmaceutical and diagnostic manufacturing sector in the region that are commencing strategic partnerships reshaped the market growth of the region. With the USA and Canada leading the region's market. RSV Diagnostics MarketThe region of Asia Pacific is anticipated to witness the highest market growth during the forecast period because of the region's high and dense population and increasing prevalence of chronic disease. The demand for technologically advanced and updated diagnostic and testing for quick and accurate diagnosis of the infection boosted the market growth in the region. Increased investments in the health care systems in the developing and developed economies such as India, china, japan, and Malaysia combined with an increased number of infants in the region further sparked the market growth of the region. Additionally, increased expenditure in the healthcare sector by the developing economies in the Middle East and African nations such as Saudi Arabia, AE, Qatar, and in South American economies such as Brazil, Argentina, and chili are attributing towards the growth of the market. Increased consumer awareness and shift of key market players in the region to tap undiscovered opportunities are some of the additional market growth factors of the region. The objective of the report is to present a comprehensive analysis of the Global RSV Diagnostics market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global RSV Diagnostics Market dynamics, structure by analyzing the market segments and project the Global RSV Diagnostics Market size. Clear representation of competitive analysis of key players by Product Type, price, financial position, Product Type portfolio, growth strategies, and regional presence in the Global RSV Diagnostics Market make the report investor’s guide.

Global RSV Diagnostics Market Scope: Inquire before buying

RSV Diagnostics Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 0.96 Bn.
Forecast Period 2022 to 2029 CAGR: 9.12% Market Size in 2029: US $ 1.96 Bn.
Segments Covered: by Product Type • Kits and Assays • Instruments
by End User • Hospitals and Clinics • Laboratories and Homecare
by Method • Molecular Diagnostics • Direct Fluorescent Antibody (DFA) Method • Rapid Antigen Detection Tests • Diagnostic Imaging • Flow Cytometry • Chromatographic Immunoassay • Others

Global RSV Diagnostics Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global RSV Diagnostics Market Key Players

• Abbott Laboratories • Dickinson and Company • Thermo Fisher Scientific Inc. • Hoffmann La Roche Limited • Novartis AG • Ortho Clinical Diagnostics • Bio-Rad Laboratories Inc. • Quidel Corporation • BioMerieux • DiaSorin SPA • Danaher Corporation • Fast Track Diagnostics • Alere, Inc. • Quest Diagnostics • Biocartis Frequently Asked Questions: 1. Which region has the largest share in Global RSV Diagnostics Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global RSV Diagnostics Market? Ans: The Global RSV Diagnostics Market is growing at a CAGR of 9.12% during forecasting period 2022-2029. 3. What is scope of the Global RSV Diagnostics market report? Ans: Global RSV Diagnostics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global RSV Diagnostics market? Ans: The important key players in the Global RSV Diagnostics Market are – Abbott Laboratories, Dickinson and Company, Thermo Fisher Scientific Inc., Hoffmann La Roche Limited, Novartis AG, Ortho Clinical Diagnostics, Bio-Rad Laboratories Inc., Quidel Corporation, BioMerieux, DiaSorin SPA, Danaher Corporation, Fast Track Diagnostics, Alere, Inc., Quest Diagnostics, and Biocartis 5. What is the study period of this market? Ans: The Global RSV Diagnostics Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Method 2.3.2. Primary Research 2.3.2.1. Data from Primary Method 2.3.2.2. Breakdown of Primary Method 3. Executive Summary: Global RSV Diagnostics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the RSV Diagnostics Product Types Market 3.4. Geographical Snapshot of the RSV Diagnostics Product Types Market, By Manufacturer share 4. Global RSV Diagnostics Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Product Types 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global RSV Diagnostics Market 5. Supply Side and Demand Side Indicators 6. Global RSV Diagnostics Market Analysis and Forecast, 2021-2029 6.1 RSV Diagnostics Market Size & Y-o-Y Growth Analysis 7. Global RSV Diagnostics Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 7.1.1. Kits and Assays 7.1.2. Instruments 7.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 7.2.1. Hospitals and Clinics 7.2.2. Laboratories and Homecare 7.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 7.3.1. Molecular Diagnostics 7.3.2. Direct Fluorescent Antibody (DFA) Method 7.3.3. Rapid Antigen Detection Tests 7.3.4. Diagnostic Imaging 7.3.5. Flow Cytometry 7.3.6. Chromatographic Immunoassay 7.3.7. Others 8. Market Size (Value) Estimates & Forecast by Region, 2021-2029 8.1.1. North America 8.1.2. South America 8.1.3. Europe 8.1.4. Asia Pacific 8.1.5. Middle East and Africa 9. North America RSV Diagnostics Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 9.1.1. Kits and Assays 9.1.2. Instruments 9.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 9.2.1. Hospitals and Clinics 9.2.2. Laboratories and Homecare 9.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 9.3.1. Molecular Diagnostics 9.3.2. Direct Fluorescent Antibody (DFA) Method 9.3.3. Rapid Antigen Detection Tests 9.3.4. Diagnostic Imaging 9.3.5. Flow Cytometry 9.3.6. Chromatographic Immunoassay 9.3.7. Others. 10. North America RSV Diagnostics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. RSV Diagnostics Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 11.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 12. Canada RSV Diagnostics Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 12.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 13. Mexico RSV Diagnostics Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 13.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 14. Europe RSV Diagnostics Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 14.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 15. Europe RSV Diagnostics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. RSV Diagnostics Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 16.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 17. France RSV Diagnostics Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 17.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 18. Germany RSV Diagnostics Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 18.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 19. Italy RSV Diagnostics Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 19.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 20. Spain RSV Diagnostics Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 20.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 21. Sweden RSV Diagnostics Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 21.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 22. CIS Countries RSV Diagnostics Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 22.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 23. Rest of Europe RSV Diagnostics Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 23.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 24. Asia Pacific RSV Diagnostics Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 24.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 25. Asia Pacific RSV Diagnostics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China RSV Diagnostics Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 26.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 27. India RSV Diagnostics Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 27.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 28. Japan RSV Diagnostics Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 28.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 29. South Korea RSV Diagnostics Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 29.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 30. Australia RSV Diagnostics Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 30.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 30.4. Market Size (Value) Estimates & Forecast By Region, 2021-2029 31. ASEAN RSV Diagnostics Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 31.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 32. Rest of Asia Pacific RSV Diagnostics Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 32.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 33. Middle East Africa RSV Diagnostics Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 33.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 34. Middle East Africa RSV Diagnostics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa RSV Diagnostics Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 35.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 36. GCC Countries RSV Diagnostics Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 36.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 37. Egypt RSV Diagnostics Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 37.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 38. Nigeria RSV Diagnostics Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 38.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 39. Rest of ME&A RSV Diagnostics Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 39.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 40. South America RSV Diagnostics Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 40.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 41. South America RSV Diagnostics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil RSV Diagnostics Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 42.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 43. Argentina RSV Diagnostics Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 43.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 44. Rest of South America RSV Diagnostics Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By End User, 2021-2029 44.3. Market Size (Value) Estimates & Forecast By Method, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global RSV Diagnostics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Methods and R&D Investment 45.2.2. New Product Type Launches and Product Type Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Bio-Rad Laboratories Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Type Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2 Abbott Laboratories 45.3.3 Dickinson and Company 45.3.4 Thermo Fisher Scientific Inc. 45.3.5 Hoffmann La Roche Limited 45.3.6 Novartis AG 45.3.7 Ortho Clinical Diagnostics 45.3.8 Quidel Corporation 45.3.9 BioMerieux 45.3.10 DiaSorin SPA 45.3.11 Danaher Corporation 45.3.12 Fast Track Diagnostics 45.3.13 Alere, Inc. 45.3.14 Quest Diagnostics 45.3.15 Biocartis 46 Primary Key Insights

About This Report

Report ID 112452
Category Healthcare
Published Date Sept 2022
Updated Date
Contact Us